Seagen Appoints David Epstein As New CEO

RTTNews | 985 dagar sedan
Seagen Appoints David Epstein As New CEO

(RTTNews) - Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors.

Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more than 25 years at Novartis where he built its oncology business unit from initiation to second largest in the world.

He then served as CEO of Novartis Pharmaceuticals, a division of Novartis AG, from 2010 to mid-2016. More recently, he was executive partner at Flagship Pioneering.

In addition, Seagen announced that Roger Dansey, M.D., who has served as Seagen's Chief Medical Officer (CMO) since 2018 and as Interim CEO since May 2022, has been appointed President, Research and Development.

In this new role, Dansey will continue to serve as CMO reporting to Epstein.

read more
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | 586 dagar sedan
Bay Street Likely To Open On Weak Note

Bay Street Likely To Open On Weak Note

Canadian shares are likely to open lower on Tuesday, tracking weak European markets amid growing uncertainty over U.S. - EU trade talks. Weak crude oil and bullion prices may hurt as well. The economic calendar is blank and there are no big earnings news as well. The mood in the market is likely to remain cautious.
RTTNews | 4h 7minuter sedan
GM Q2 Results Down, Yet Beat Market; Backs FY25 View; Shares Hit

GM Q2 Results Down, Yet Beat Market; Backs FY25 View; Shares Hit

Automajor General Motors Co. on Tuesday maintained its fiscal 2025 earnings outlook, after reporting weak profit and revenues in its second quarter. However, adjusted earnings and top line beat market estimates. In the pre-market activity on the NYSE, General Motors shares were losing around 3.7 percent.
RTTNews | 5h 29minuter sedan
FTSE Flat At Noon; Compass Group, Centrica Post Strong Gains

FTSE Flat At Noon; Compass Group, Centrica Post Strong Gains

U.K. stocks are turning in a mixed performance in cautious trade on Tuesday with investors reacting to some earnings updates, and assessing the possible move of the U.S. and the European Union in the event of the ongoing trade negotiations failing to result in any meaningful solution to the tariff issues.
RTTNews | 5h 30minuter sedan
UK Budget Deficit Exceeds Estimate In June

UK Budget Deficit Exceeds Estimate In June

The UK budget deficit widened more than estimated in June on higher debt servicing costs, which has added pressure on Chancellor Rachel Reeves to raise taxes at the autumn budget. Public sector net borrowing rose by GBP 6.6 billion from the previous year to GBP 20.7 billion in June, the Office for National Statistics reported Tuesday.
RTTNews | 5h 37minuter sedan